CVS Paying $77.6 Million in Pseudoephedrine Case

The company said it has fixed the "electronic monitoring system flaw" that caused a "lapse in controls of PSE sales in certain CVS/pharmacy stores in 2007 and 2008."

CVS/pharmacy, the retail division of CVS Caremark Corporation, Thursday afternoon announced it has agreed with the U.S. Drug Enforcement Administration and U.S. attorneys' offices to pay a $75 million civil settlement and forfeit $2.6 million in profits, along with maintaining certain compliance measures, for not controlling sales of pseudoephedrine at certain California and Nevada stores in 2007 and 2008. The company said it has fixed the "electronic monitoring system flaw" that caused a "lapse in controls of PSE sales in certain CVS/pharmacy stores in 2007 and 2008."

Pseudoephedrine sales are controlled because it is used to manufacture methamphetamine.

The company said the settlement "acknowledges that a distribution center in California failed to monitor and report excessive PSE sales by CVS/pharmacy stores" and is related only to the retail pharmacy business. An electronic monitoring system recorded individual PSE sales, but as implemented in California, Nevada, "and certain other states," according to the company's statement, "the system did not prevent multiple sales of PSE that totaled more than the federal daily legal limit, which made certain CVS/pharmacy stores vulnerable to criminals who intended to purchase large amounts of PSE. The excessive sales occurred primarily in California and Nevada. The settlement includes not only federal jurisdictions in California and Nevada, but also federal jurisdictions in twenty-three other states where the system was not implemented properly."

"We are announcing today that we have resolved this issue, which unfortunately resulted from a breakdown in CVS/pharmacy's normally high management and oversight standards," Thomas M. Ryan, chairman and CEO of CVS Caremark, said in the statement. "While this lapse occurred in 2007 and 2008 and has been addressed, it was an unacceptable breach of the company's policies and was totally inconsistent with our values. CVS/pharmacy is unwavering in its support of the measures taken by the federal government and the states to prevent drug abuse. To make certain this kind of lapse never takes place again, we have strengthened our internal controls and compliance measures and made substantial investments to improve our handling and monitoring of PSE by implementing enhanced technology and making other improvements in our stores and distribution centers."

CVS/pharmacy has more than 7,100 CVS/pharmacy and Longs Drug stores.

Download Center

HTML - No Current Item Deck
  • Safety Management Software - Free Demo

    IndustrySafe Safety Software’s comprehensive suite of modules help organizations to record and manage incidents, inspections, hazards, behavior based safety observations, and much more. Improve safety with an easy to use tool for tracking, notifying and reporting on key safety data.

  • Create Flexible Safety Dashboards

    IndustrySafe’s Dashboard Module allows organizations allows you to easily create and view safety KPIs to help you make informed business decisions. Our best of breed default indicators can also save you valuable time and effort in monitoring safety metrics.

  • Get the Ultimate Guide to OSHA Recordkeeping

    OSHA’s Form 300A posting deadline is February 1! Are you prepared? To help answer your key recordkeeping questions, IndustrySafe put together this guide with critical compliance information.

  • The 4 Stages of an Incident Investigation

    So, your workplace has just experienced an incident resulting in the injury or illness of a worker. Now what? OSHA recommends that you conduct investigations of workplace incidents using a four-step system.

  • Why Is Near Miss Reporting Important?

    A near miss is an accident that's waiting to happen. Learn how to investigate these close calls and prevent more serious incidents from occurring in the future.

  • Industry Safe
comments powered by Disqus

Free Whitepaper

Stand Your Ground: A Guide to Slip Resistance in Industrial Safety Footwear

This white paper helps to clarify this complexity, so you can better navigate the standards and better ensure the safety of your employees.

Download Now →

OH&S Digital Edition

  • OHS Magazine Digital Edition - November December 2019

    November/December 2019

    Featuring:

    • GAS DETECTION
      Redefining Compliance for the Gas Detection Buyer
    • FALL PROTECTION
      Don't Trip Over the Basics
    • VISION PROTECTION
      What to Look for in Head-to-Toe PPE Solutions
    • PROTECTIVE APPAREL
      Effective PPE for Flammable Dust
    View This Issue